Sanofi is ending a mid-stage program for isatuximab for acute lymphoblastic leukemia, and SAR428926, an anti-LAMP1 ADC for solid tumors. Source: BioSpace

Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn. Source: BioSpace

The company presented a late-breaker poster and corresponding oral presentation at the conference. Source: BioSpace

Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly. Source: BioSpace

Since Friday, the stock market has been volatile, to say the least. Source: BioSpace

This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace

It's the end of the road for Cambridge, MA based Enumeral Biomedical. Source: BioSpace

Natalizumab did not demonstrate improvement in clinical outcomes compared to placebo. Source: BioSpace

Since Emma Walmsley took over leadership at Glaxo, expectations have been both high and hypercritical. Source: BioSpace

Bexsero is the first vaccine in the world to receive the designation twice. Source: BioSpace